Eko Health
Next year, AI will move beyond administrative support to become a workflow-integrated tool that drives predictive and proactive care and sees true adoption, according to healthcare leaders.
Executives pointed to faster-than-expected AI adoption in healthcare, shifting regulatory signals and growing demand for AI tools that deliver measurable outcomes.
Clinicians in the UK now have access to the company's AI-powered cardiac and pulmonary assessment tools via the company’s website and Amazon UK.
Eko Health added to its board of directors, and Medtronic announced a new chief medical officer for robotics and digital technologies.
Cardiac and lung-disease platform Eko Health secured $41 million in Series D funding.
The Eko Low Ejection Fraction Tool will be added to the company's cardiac early detection platform, which already includes various algorithms to inspect heart health.